Mytrus

Wednesday, March 19, 2014

Mytrus, a provider of electronic informed consent and e-clinical technologies, has created a new Innovation Advisory Board comprised of industry experts to help shape the future of its clinical products and services.

Wednesday, May 22, 2013

The WIRB-Copernicus Group, the world’s largest provider of regulatory and ethical review services for human research, has partnered with Mytrus, a clinical technology and services company, to deliver a unique electronic informed consent solution that will help to streamline and enrich the clinical research process.

Wednesday, March 13, 2013

inVentiv Health, based in Burlington, Mass., has taken an equity stake in Mytrus, a pioneer in virtual clinical trials and technologies including electronic informed consent to improve trial efficiency.

Tuesday, December 18, 2012

The University of Alabama at Birmingham (UAB) will use an iPad application developed by Mytrus, a clinical technology and services company for medical and pharmaceutical research, in an upcoming pilot study supported by the U.S. Department of Health & Human Services Agency for Healthcare Research and Quality.

Wednesday, September 12, 2012

Mytrus, a San Francisco-based innovative clinical technology and services company, announced that its iPad application explaining informed consent prior to clinical trial patient enrollment has been selected for use in a global, multi-year study supported by the National Institute of Neurological Disorders and Stroke (NINDS).

Wednesday, August 24, 2011

Greenphire, based in suburban Philadelphia, and San Francisco startup Mytrus have developed web-based solutions to streamline the arduous tasks of recruiting, retaining, and efficiently administering clinical trials. Greenphire’s ClinCard System, a web-based patient payment, management, and communication platform, compliments the functionality offered by Mytrus and its innovative methods for allowing patients to participate in clinical research studies directly from their own homes.

Monday, June 20, 2011

As Pfizer begins enrolling the first-ever FDA-approved “virtual” clinical trial, which allows patients to participate from home using smartphones and computers instead of visiting a clinic, industry executives believe the study has far-reaching implications for improving the productivity of clinical trials in the future.